• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[抗精神病药物治疗下的代谢紊乱]

[Metabolic disorders under antipsychotic treatment].

作者信息

Steffenhagen N, Rummel-Kluge C, Himmerich H

机构信息

Klinik und Poliklinik für Psychiatrie, Medizinische Fakultät der Universität Leipzig, Semmelweisstr. 10, 04103, Leipzig, Deutschland.

出版信息

Nervenarzt. 2012 Mar;83(3):337-44. doi: 10.1007/s00115-010-3207-1.

DOI:10.1007/s00115-010-3207-1
PMID:21206997
Abstract

Patients with severe mental illness, such as schizophrenia, depression or bipolar disorder, are more likely to be overweight and to suffer from dyslipidaemia, diabetes or cardiovascular disease. Unhealthy lifestyles, including poor diet and sedentary behaviour, but also pharmacotherapy contribute to the adverse risk profile. This article reviews the epidemiology and pharmacodynamics of metabolic abnormalities in psychiatric patients treated with antipsychotics, focusing on substance-specific differences.

摘要

患有严重精神疾病(如精神分裂症、抑郁症或双相情感障碍)的患者更有可能超重,并患有血脂异常、糖尿病或心血管疾病。不健康的生活方式,包括不良饮食和久坐不动的行为,以及药物治疗,都会导致不良风险状况。本文综述了接受抗精神病药物治疗的精神病患者代谢异常的流行病学和药效学,重点关注药物特异性差异。

相似文献

1
[Metabolic disorders under antipsychotic treatment].[抗精神病药物治疗下的代谢紊乱]
Nervenarzt. 2012 Mar;83(3):337-44. doi: 10.1007/s00115-010-3207-1.
2
[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].[制定重症精神疾病患者身体健康检查指南]
Encephale. 2009 Sep;35(4):330-9. doi: 10.1016/j.encep.2008.10.014. Epub 2009 Jul 9.
3
Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics.使用第二代抗精神病药物治疗的双相情感障碍和精神分裂症患者患代谢综合征的风险同样增加。
Bipolar Disord. 2008 Nov;10(7):788-97. doi: 10.1111/j.1399-5618.2008.00625.x.
4
The METEOR study: frequency of metabolic disorders in patients with schizophrenia. Focus on first and second generation and level of risk of antipsychotic drugs.METEOR 研究:精神分裂症患者代谢紊乱的频率。关注第一代和第二代抗精神病药物以及风险水平。
Int Clin Psychopharmacol. 2011 Nov;26(6):291-302. doi: 10.1097/YIC.0b013e32834a5bf6.
5
Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial.首发精神分裂症的代谢风险因素:来自欧洲首发精神分裂症试验的基线患病率和病程分析。
Int J Neuropsychopharmacol. 2013 Jun;16(5):987-95. doi: 10.1017/S1461145712001241. Epub 2012 Dec 20.
6
Metabolic and cardiovascular adverse events associated with antipsychotic treatment in children and adolescents.儿童和青少年抗精神病药物治疗相关的代谢及心血管不良事件。
Arch Pediatr Adolesc Med. 2008 Oct;162(10):929-35. doi: 10.1001/archpedi.162.10.929.
7
Schizophrenia and comorbid metabolic disorders.精神分裂症与共病代谢紊乱。
J Clin Psychiatry. 2005;66 Suppl 6:11-20.
8
Implementation of monitoring and management guidelines for second-generation antipsychotics.第二代抗精神病药物监测与管理指南的实施
J Clin Psychiatry. 2007;68 Suppl 4:14-8.
9
Metabolic and endocrine disturbances in psychiatric disorders: a multidisciplinary approach to appropriate atypical antipsychotic utilization.精神疾病中的代谢和内分泌紊乱:合理使用非典型抗精神病药物的多学科方法。
CNS Spectr. 2005 Oct;10(10):suppl14 1-15.
10
Association of adiponectin and metabolic syndrome among patients taking atypical antipsychotics for schizophrenia: a cohort study.服用非典型抗精神病药物治疗精神分裂症患者中脂联素与代谢综合征的关联:一项队列研究。
Schizophr Res. 2009 Jun;111(1-3):1-8. doi: 10.1016/j.schres.2009.03.014. Epub 2009 May 5.

引用本文的文献

1
Aerobic Exercise Improves the Overall Outcome of Type 2 Diabetes Mellitus Among People With Mental Disorders.有氧运动改善精神障碍患者2型糖尿病的总体预后。
Depress Anxiety. 2024 Dec 31;2024:6651804. doi: 10.1155/da/6651804. eCollection 2024.
2
[Nutrition and dietary supplements in psychiatric diseases].[精神疾病中的营养与膳食补充剂]
Nervenarzt. 2014 Dec;85(12):1512-20. doi: 10.1007/s00115-014-4163-y.

本文引用的文献

1
Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.二代抗精神病药治疗精神分裂症时代谢副作用的头对头比较:系统评价和荟萃分析。
Schizophr Res. 2010 Nov;123(2-3):225-33. doi: 10.1016/j.schres.2010.07.012. Epub 2010 Aug 7.
2
Efficacy and tolerability of paliperidone ER and other oral atypical antipsychotics in schizophrenia.帕利哌酮缓释片与其他口服非典型抗精神病药物治疗精神分裂症的疗效及耐受性
Int J Clin Pharmacol Ther. 2010 Jun;48(6):383-99. doi: 10.5414/cpp48383.
3
[Antihistaminergic antipsychotics cause weight gain].
Nervenarzt. 2010 Mar;81(3):329-34. doi: 10.1007/s00115-009-2870-6.
4
Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC).欧洲精神病学协会(EPA)发布的关于严重精神疾病患者心血管疾病和糖尿病的立场声明,得到了欧洲糖尿病研究协会(EASD)和欧洲心脏病学会(ESC)的支持。
Eur Psychiatry. 2009 Sep;24(6):412-24. doi: 10.1016/j.eurpsy.2009.01.005. Epub 2009 Aug 13.
5
Are weight gain and metabolic side effects of atypical antipsychotics dose dependent? A literature review.非典型抗精神病药物的体重增加和代谢副作用是否存在剂量依赖性?文献综述。
J Clin Psychiatry. 2009 Jul;70(7):1041-50. doi: 10.4088/jcp.08r04392.
6
Somatic hospital contacts, invasive cardiac procedures, and mortality from heart disease in patients with severe mental disorder.患有严重精神障碍患者的躯体医院就诊情况、侵入性心脏手术及心脏病死亡率。
Arch Gen Psychiatry. 2009 Jul;66(7):713-20. doi: 10.1001/archgenpsychiatry.2009.61.
7
[Genetics of weight gain associated with antipsychotic medications].[与抗精神病药物相关的体重增加的遗传学]
Nervenarzt. 2009 May;80(5):556-63. doi: 10.1007/s00115-008-2650-8.
8
Which comes first: atypical antipsychotic treatment or cardiometabolic risk?哪个先出现:非典型抗精神病药物治疗还是心脏代谢风险?
Acta Psychiatr Scand. 2009 Mar;119(3):171-9. doi: 10.1111/j.1600-0447.2008.01334.x.
9
Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study.在CATIE精神分裂症研究中抗精神病药物对估计的10年冠心病风险的影响。
Schizophr Res. 2008 Oct;105(1-3):175-87. doi: 10.1016/j.schres.2008.07.006. Epub 2008 Sep 4.
10
First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis.第一代与第二代抗精神病药物及精神分裂症患者患糖尿病的风险:系统评价与荟萃分析
Br J Psychiatry. 2008 Jun;192(6):406-11. doi: 10.1192/bjp.bp.107.037184.